Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Dec 9;9(1):18991. doi: 10.1038/s41598-019-54421-6.

2.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
3.

Editorial: Skin Blistering Diseases.

Has C, Amber KT, Murrell DF, Musette P, Ludwig RJ.

Front Med (Lausanne). 2019 Apr 2;6:60. doi: 10.3389/fmed.2019.00060. eCollection 2019. No abstract available.

4.

A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils.

Janela B, Patel AA, Lau MC, Goh CC, Msallam R, Kong WT, Fehlings M, Hubert S, Lum J, Simoni Y, Malleret B, Zolezzi F, Chen J, Poidinger M, Satpathy AT, Briseno C, Wohn C, Malissen B, Murphy KM, Maini AA, Vanhoutte L, Guilliams M, Vial E, Hennequin L, Newell E, Ng LG, Musette P, Yona S, Hacini-Rachinel F, Ginhoux F.

Immunity. 2019 Apr 16;50(4):1069-1083.e8. doi: 10.1016/j.immuni.2019.03.001. Epub 2019 Mar 27.

PMID:
30926233
5.

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Mar 5;9(1):3525. doi: 10.1038/s41598-019-40203-7. Erratum in: Sci Rep. 2019 Dec 9;9(1):18991.

6.

Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients.

Bensussan A, Janela B, Thonnart N, Bagot M, Musette P, Ginhoux F, Marie-Cardine A.

J Invest Dermatol. 2019 Mar;139(3):725-728. doi: 10.1016/j.jid.2018.09.026. Epub 2018 Oct 25. No abstract available.

PMID:
30798854
7.

Long-Term Increase of Kcnn4 Potassium Channel Surface Expression on B Cells in Pemphigus Patients after Rituximab Treatment.

Caillot F, Derambure C, Berkani N, Riou G, Maho-Vaillant M, Calbo S, Joly P, Musette P.

J Invest Dermatol. 2018 Dec;138(12):2666-2668. doi: 10.1016/j.jid.2018.05.034. Epub 2018 Jul 2. No abstract available.

8.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

9.

B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.

Musette P, Bouaziz JD.

Front Immunol. 2018 Apr 13;9:622. doi: 10.3389/fimmu.2018.00622. eCollection 2018. Review.

10.

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.

Musette P, Janela B.

Front Med (Lausanne). 2017 Dec 4;4:179. doi: 10.3389/fmed.2017.00179. eCollection 2017. Review.

11.

Anti-epileptic drugs induce cutaneous lymphocyte-associated antigen downregulation leading to potential human herpes virus-7 reactivation in clinically asymptomatic patients.

Caillot F, Andrieu E, Houivet E, Duvert-Lehembre S, Calbo S, Sabbah B, Maltete D, Martinaud O, Le Goff F, Malekpour P, Berard M, Rogez S, Joly P, Picard D, Musette P.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e41-e43. doi: 10.1111/jdv.14493. Epub 2017 Oct 10. No abstract available.

PMID:
28758263
12.

A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms.

Deschamps A, Samain A, Carvalho P, Courville P, Levesque H, Musette P, Joly P.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e16-e17. doi: 10.1111/jdv.14432. Epub 2017 Jul 28. No abstract available.

PMID:
28653374
13.

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.

Derambure C, Dzangue-Tchoupou G, Berard C, Vergne N, Hiron M, D'Agostino MA, Musette P, Vittecoq O, Lequerré T.

Arthritis Res Ther. 2017 May 25;19(1):109. doi: 10.1186/s13075-017-1319-8.

14.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases.

Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.

PMID:
28342637
15.

New Approaches to Investigate Drug-Induced Hypersensitivity.

Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ.

Chem Res Toxicol. 2017 Jan 17;30(1):239-259. doi: 10.1021/acs.chemrestox.6b00333. Epub 2016 Nov 15. Review.

PMID:
27806199
16.

Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function.

Guillou C, Fréret M, Fondard E, Derambure C, Avenel G, Golinski ML, Verdet M, Boyer O, Caillot F, Musette P, Lequerré T, Vittecoq O.

Sci Rep. 2016 Mar 30;6:23796. doi: 10.1038/srep23796.

17.

Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies.

Chatillon JF, Hamieh M, Bayeux F, Abasq C, Fauquembergue E, Drouet A, Guisier F, Latouche JB, Musette P.

Immun Inflamm Dis. 2015 Mar;3(1):1-13. doi: 10.1002/iid3.43. Epub 2015 Feb 19.

18.

Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate.

Lin W, Cerny D, Chua E, Duan K, Yi JT, Shadan NB, Lum J, Maho-Vaillant M, Zolezzi F, Wong SC, Larbi A, Fink K, Musette P, Poidinger M, Calbo S.

J Immunol. 2014 Sep 1;193(5):2258-66. doi: 10.4049/jimmunol.1303214. Epub 2014 Jul 30.

19.

Recurrence of drug-induced reactions in DRESS patients.

Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P.

J Eur Acad Dermatol Venereol. 2015 Apr;29(4):801-4. doi: 10.1111/jdv.12419. Epub 2014 Mar 13.

PMID:
24628777
20.

Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features.

Tetart F, Picard D, Janela B, Joly P, Musette P.

JAMA Dermatol. 2014 Feb;150(2):206-7. doi: 10.1001/jamadermatol.2013.6698. No abstract available.

PMID:
24369386
21.

Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus.

Gamonet C, Ferrand C, Colliou N, Musette P, Joly P, Girardin M, Humbert P, Aubin F.

Exp Dermatol. 2014 Jan;23(1):66-7. doi: 10.1111/exd.12299.

PMID:
24313590
22.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

23.

Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.

Cacoub P, Descamps V, Meyer O, Speirs C, Belissa-Mathiot P, Musette P.

Osteoporos Int. 2013 May;24(5):1751-7. doi: 10.1007/s00198-013-2265-1. Epub 2013 Jan 30.

PMID:
23361875
24.

Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis.

Camous X, Calbo S, Picard D, Musette P.

Curr Opin Immunol. 2012 Dec;24(6):730-5. doi: 10.1016/j.coi.2012.07.010. Epub 2012 Oct 11. Review.

PMID:
23062470
25.

Poor benefit/risk balance of intravenous immunoglobulins in DRESS.

Joly P, Janela B, Tetart F, Rogez S, Picard D, D'Incan M, Descamps V, Collet E, Roujeau JC, Musette P.

Arch Dermatol. 2012 Apr;148(4):543-4. doi: 10.1001/archderm.148.4.dlt120002-c. No abstract available.

PMID:
22508885
26.

The DRESS syndrome: a literature review.

Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC.

Am J Med. 2011 Jul;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017. Epub 2011 May 17. Review.

PMID:
21592453
27.

Cutaneous side effects of antiosteoporosis treatments.

Musette P, Kaufman JM, Rizzoli R, Cacoub P, Brandi ML, Reginster JY.

Ther Adv Musculoskelet Dis. 2011 Feb;3(1):31-41. doi: 10.1177/1759720X10387202.

28.

Role of toll-like receptor 4 in the inflammation reaction surrounding silicone prosthesis.

Auquit-Auckbur I, Caillot F, Arnoult C, Menard JF, Drouot L, Courville P, Tron F, Musette P.

Acta Biomater. 2011 May;7(5):2047-52. doi: 10.1016/j.actbio.2011.01.030. Epub 2011 Jan 25.

PMID:
21272673
29.

IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P.

Eur J Immunol. 2010 Oct;40(10):2686-91. doi: 10.1002/eji.201040673.

30.

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P.

Sci Transl Med. 2010 Aug 25;2(46):46ra62. doi: 10.1126/scitranslmed.3001116.

31.

Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Müller R, Hunzelmann N, Baur V, Siebenhaar G, Wenzel E, Eming R, Niedermeier A, Musette P, Joly P, Hertl M.

Dermatol Res Pract. 2010;2010:321950. doi: 10.1155/2010/321950. Epub 2010 Jun 30.

32.

Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.

Musette P, Brandi ML, Cacoub P, Kaufman JM, Rizzoli R, Reginster JY.

Osteoporos Int. 2010 May;21(5):723-32. doi: 10.1007/s00198-009-1097-5. Epub 2009 Nov 17. Review.

PMID:
19921087
33.

Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.

Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.

J Immunol. 2009 Nov 15;183(10):6207-16. doi: 10.4049/jimmunol.0803219. Epub 2009 Oct 19.

34.

ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P.

Arch Dermatol. 2009 May;145(5):529-35. doi: 10.1001/archdermatol.2009.9.

PMID:
19451496
35.

Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock.

Boet S, Noblet C, Haas-Hubscher C, Picard D, Musette P, Dureuil B.

Eur J Anaesthesiol. 2009 Sep;26(9):791-3. doi: 10.1097/EJA.0b013e32832ac3a6. No abstract available.

PMID:
19424074
36.

Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice.

Benhamou Y, Favre J, Musette P, Renet S, Thuillez C, Richard V, Tamion F.

Crit Care Med. 2009 May;37(5):1724-8. doi: 10.1097/CCM.0b013e31819da805.

PMID:
19325486
37.

Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.

Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V.

Arch Dermatol. 2009 Jan;145(1):67-72. doi: 10.1001/archderm.145.1.67.

PMID:
19153346
38.

B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses.

Mouquet H, Musette P, Gougeon ML, Jacquot S, Lemercier B, Lim A, Gilbert D, Dutot I, Roujeau JC, D'Incan M, Bedane C, Tron F, Joly P.

J Invest Dermatol. 2008 Dec;128(12):2859-69. doi: 10.1038/jid.2008.178. Epub 2008 Jun 19.

39.

[Imatinib-induced DRESS].

Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, Joly P.

Ann Dermatol Venereol. 2008 May;135(5):393-6. doi: 10.1016/j.annder.2007.10.007. Epub 2008 Apr 21. French.

PMID:
18457727
40.

Case 36-2007: a woman with rash, fever, and hypotension.

Descamps V, Joly P, Musette P.

N Engl J Med. 2008 Mar 27;358(13):1406; author reply 1406-7. No abstract available.

PMID:
18376448
41.

[Drug-induced hypersensitivity syndrome due to gabapentin].

Goldman J, Duval-Modeste AB, Musette P, Joly P, Massy N, Courville C, Rabehenoina A.

Ann Dermatol Venereol. 2008 Mar;135(3):230-2. doi: 10.1016/j.annder.2007.11.016. Epub 2008 Mar 4. French. No abstract available.

PMID:
18374860
42.

Toll-like receptor 9 in murine lupus: more friend than foe!

Yu P, Musette P, Peng SL.

Immunobiology. 2008;213(2):151-7. doi: 10.1016/j.imbio.2007.08.002. Epub 2007 Sep 21. Review.

PMID:
18241699
43.

[Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx)].

Verdier E, Carvalho P, Young P, Musette P, Courville P, Joly P.

Ann Dermatol Venereol. 2007 Oct;134(10 Pt 1):760-3. French.

PMID:
17978715
44.

Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.

Begon E, Michel L, Flageul B, Beaudoin I, Jean-Louis F, Bachelez H, Dubertret L, Musette P.

Eur J Dermatol. 2007 Nov-Dec;17(6):497-506. Epub 2007 Oct 19.

PMID:
17951129
45.

A single cycle of rituximab for the treatment of severe pemphigus.

Joly P, Mouquet H, Roujeau JC, D'Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P.

N Engl J Med. 2007 Aug 9;357(6):545-52.

46.

Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.

Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1064-71. Epub 2007 Mar 1.

PMID:
17332486
47.

Rituximab for pemphigus vulgaris.

Joly P, D'Incan M, Musette P.

N Engl J Med. 2007 Feb 1;356(5):521; author reply 521-2. No abstract available.

PMID:
17267915
48.

Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus.

Lartigue A, Courville P, Auquit I, François A, Arnoult C, Tron F, Gilbert D, Musette P.

J Immunol. 2006 Jul 15;177(2):1349-54.

49.

[Cutaneous expression and function of Toll-like receptors].

Musette P, Auquit Auckbur I, Begon E.

Ann Dermatol Venereol. 2006 Mar;133(3):268-71. Review. French. No abstract available.

PMID:
16800181
50.

TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation.

Cottalorda A, Verschelde C, Marçais A, Tomkowiak M, Musette P, Uematsu S, Akira S, Marvel J, Bonnefoy-Berard N.

Eur J Immunol. 2006 Jul;36(7):1684-93.

Supplemental Content

Loading ...
Support Center